Commons Capital, LLC Cardiol Therapeutics Inc. Call Options Transaction History
Commons Capital, LLC
- $109 Million
- Q4 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding CRDL
# of Institutions
46Shares Held
7.58MCall Options Held
4.9KPut Options Held
3.8K-
Tejara Capital LTD London, X03.12MShares$3.43 Million2.61% of portfolio
-
Advisor Shares Investments LLC Bethesda, MD882KShares$970,7360.23% of portfolio
-
Mmcap International Inc. Spc Grand Cayman, E9796KShares$875,1870.31% of portfolio
-
Pvg Asset Management Corp Golden, CO487KShares$536,0243.54% of portfolio
-
Cambridge Investment Research Advisors, Inc.331KShares$363,5550.0% of portfolio
About Cardiol Therapeutics Inc.
- Ticker CRDL
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 61,942,500
- Market Cap $68.1M
- Description
- Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of cardiovascular disease (CVD). Its lead product is CardiolRx, which is in Phase II/III multi-national, randomized, double-blind, and placebo-controlled study to evaluate t...